Sean Moran

2017 - Corbus Pharmaceuticals Holdings

In 2017, Sean Moran earned a total compensation of $1.2M as Chief Financial Officer at Corbus Pharmaceuticals Holdings, a 20% decrease compared to previous year.

Compensation breakdown

Bonus$140,700
Option Awards$765,210
Salary$335,000
Total$1,240,910

Moran received $765.2K in option awards, accounting for 62% of the total pay in 2017.

Moran also received $140.7K in bonus and $335K in salary.

Rankings

In 2017, Sean Moran's compensation ranked 7,943rd out of 14,666 executives tracked by ExecPay. In other words, Moran earned more than 45.8% of executives.

ClassificationRankingPercentile
All
7,943
out of 14,666
46th
Division
Manufacturing
2,981
out of 5,772
48th
Major group
Chemicals And Allied Products
977
out of 2,075
53rd
Industry group
Drugs
763
out of 1,731
56th
Industry
Pharmaceutical Preparations
600
out of 1,333
55th
Source: SEC filing on April 13, 2018.

Moran's colleagues

We found three more compensation records of executives who worked with Sean Moran at Corbus Pharmaceuticals Holdings in 2017.

2017

Yuval Cohen

Corbus Pharmaceuticals Holdings

Chief Executive Officer

2017

Barbara White

Corbus Pharmaceuticals Holdings

Chief Medical Officer

2017

Mark Tepper

Corbus Pharmaceuticals Holdings

Chief Scientific Officer

In-depth

You may also like